• -
70 Results
Medical law
Promoted Yet Unproven: How State Laws Expand Access to Unchecked Stem Cell Interventions
The safety and efficacy of many stem cell treatments remain unproven by the FDA, yet state laws promote access and use of these unchecked and potentially harmful treatments. Fellow Kirstin R.W. Matthews summarizes her recent publication in a new commentary — outlining public health consequences of these state laws and calling for scientific societies’ advocacy in state policymaking.
Kirstin R.W. Matthews May 13, 2024
Balancing Safety and Innovation: Shaping Responsible Carbon Nanotube Policy
Qualities like amazing tensile strength and electrical conductivity offer a huge range of uses for carbon nanotubes. In a new policy brief, fellow Rachel A. Meidl and her co-authors Dana Goerzen and Daniel A. Heller explain that to ensure carbon nanotubes’ role in a circular, sustainable economy, a coordinated system for classifying, testing, and identifying CNTs and a life cycle approach to risk assessments are needed to better understand impacts to facilitate consistent communication among researchers, industries, and policymakers.
Dana Goerzen, Daniel A. Heller, Rachel A. Meidl February 28, 2024
Lab sample pipette
One Easy Way to Increase Transparency in Human Embryo Research
For research involving human embryos and other controversial subjects, science journals should require ethics statements from researchers detailing research oversight, what embryos were used, how many and for how long. This will help increase transparency and improve communication with the public, writes Science and Technology Policy Fellow Kirstin R.W. Matthews.
Kirstin R.W. Matthews January 9, 2024
Women in lab
From Overlooked to Nobel Laureate: Katalin Karikó’s Journey
The work of Katalin Karikó, 2023 Nobel Prize in Medicine recipient, laid a foundation for the development of COVID-19 mRNA vaccines that saved close to 20 million lives worldwide. But her discoveries almost did not happen, writes Alicia L. Johnson, a civic science postdoctoral associate at the Baker Institute Center for Health and Biosciences. Karikó’s story highlights the vital importance of supporting women in STEM.
Alicia L. Johnson October 30, 2023
Stem cell
Unproven Stem Cell Interventions: How Texas Can Promote Patient Safety and Education
The market for stem cell therapies is growing, but most of these treatments are still experimental — and patients who undergo them risk experiencing serious side effects. This quick take offers three recommendations to improve patient safety and education around stem cell interventions in Texas.
Kirstin R.W. Matthews, Akshaya Venkatesh April 27, 2023